Urolithin A: Science & Research

Urolithin A: Science & Research

A curated hub of peer-reviewed research, expert insight, and educational content on one of the most promising longevity compounds in nutritional science.

What Is Urolithin A?

Urolithin A (UA) is a natural compound produced when gut bacteria metabolize ellagitannins — polyphenols found in pomegranates, walnuts, and certain berries. Its defining biological action is the activation of mitophagy: the cellular process that clears out damaged mitochondria and stimulates the growth of new, healthy ones.

Because mitochondrial decline is a central driver of aging across virtually every tissue in the body, Urolithin A has attracted significant attention from leading longevity researchers worldwide. It is currently the only food-derived compound known to directly reactivate the mitophagy pathway.

Read the full explainer →

Key Human Clinical Trials

Urolithin A has been studied in multiple peer-reviewed, randomized controlled trials in humans. Here are the most significant findings:

Study Journal Key Finding
Andreux et al., 2019 Nature Metabolism First human safety trial: UA well-tolerated at all doses; measurable mitophagy gene activation in muscle biopsies at 500–1,000 mg/day
Singh et al., 2022 JAMA Network Open 66 older adults over 4 months: significant improvement in muscle endurance and mitochondrial biomarkers vs. placebo at 1,000 mg/day
Ryu et al., 2016 Nature Medicine Landmark preclinical study establishing UA as the first food-derived mitophagy activator; improved exercise capacity in aged models
Cycling performance, 2023 Eur. Journal of Sport Science Trained athletes: improved endurance time-to-exhaustion and reduced oxidative stress markers after 3 weeks of UA supplementation

Read the full clinical research breakdown →

The Gut Microbiome Factor

Not everyone can produce Urolithin A from food — and the difference comes down entirely to gut microbiome composition. Research identifies three “metabotypes”:

  • Metabotype A (~35%): Efficient UA producers from dietary sources
  • Metabotype B (~45%): Partial producers of mixed urolithins
  • Metabotype 0 (~20%): Non-producers — no detectable UA despite dietary intake

This means eating pomegranates or walnuts will not reliably deliver therapeutic Urolithin A levels for a significant portion of the population. Direct supplementation bypasses this variability entirely.

Read the full microbiome article →

Urolithin A & Muscle Health

Skeletal muscle is among the most mitochondria-dense tissues in the body, making it highly sensitive to mitochondrial quality decline. UA research demonstrates consistent benefits for:

  • Muscle endurance and fatigue resistance
  • Protection against age-related muscle loss (sarcopenia)
  • Enhanced mitochondrial biogenesis alongside exercise

The 2022 JAMA Network Open trial is the most clinically rigorous evidence to date, showing functional physical improvements in older adults over a 4-month period.

Read the full muscle health article →

Areas of Emerging Research

Beyond muscle and mitochondria, active research is exploring UA’s potential relevance to:

  • Brain health: Neuronal mitochondrial dysfunction is implicated in Alzheimer’s and Parkinson’s; preclinical UA studies show neuroprotective signals
  • Cardiovascular function: Cardiomyocytes are exceptionally mitochondria-dependent; UA studies in cardiac tissue show favorable outcomes
  • Immune aging: T-cell and macrophage function decline with mitochondrial dysregulation; UA may support immune resilience
  • Anti-inflammatory effects: Reduction in inflammatory cytokine production observed in multiple studies

These areas are promising but are in earlier stages of human investigation. We will continue updating this page as the science evolves.

All Research Articles

Last updated: May 2026. Content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any supplement.